uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted March 09, 2021

CBD Seller Warned for Drug and COVID-19 Claims

On March 1, 2021, the FDA issued a warning letter to Cannafyl following a review of the company's website, which found statements made about the company's products Balance CBD Drops, Relief CBD Drops, Relax CBD Drops and Relief CBD Salve to be drug claims. In addition, the products were sold with unsupported claims that they can treat coronavirus (COVID-19).

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at